Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-28

Clinical Trial Update: Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial update on treating suicidal behavior and self-mutilation in people with Borderline Personality Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Borderline Personality Disorder | Phase 4 | Status: COMPLETED | Results posted: 2017-08-28